DigiNepal

A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity

Oncology Research · Yang Liu, Lixue Chen, Peng Wang et al. · 2026

  • EnglishRead in your language
  • CitedEvery fact sourced
  • Ad-freeNo ads, no tracking

Quick facts

Author
Yang Liu, Lixue Chen, Peng Wang, Xiaoli Ma, Shuaikang Pan, Dafu Yang, Tianyu Zhou, Fang Yu ref
Published
ref
Publisher
Tech Science Press ref
Journal
Oncology Research ref

Questions

Who wrote A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity?
A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity was written by Yang Liu, Lixue Chen, Peng Wang, Xiaoli Ma.
When was A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity first published?
A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity was first published in 2026.

Sources

  1. Publisher record (DOI, via Crossref)

Last updated · facts checked 23 October 2026

Cite this page

"A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity". DigiNepal. Last updated 23 October 2026. https://diginpl.com/books/paper-or-2026-089127. Retrieved 14 November 2026.

Machine-readable versions: JSON · Markdown

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.089127.

← Books